Arterial Remodeling Technologies To Report That Its Bioresorbable Stent Platform Restores the Remodeling Capacity of Arterial Walls

Published: Jan 04, 2010

Bookmark and Share

PARIS--(BUSINESS WIRE)--Arterial Remodeling Technologies (“ART”) announced today that it has disclosed impressive in vivo and in vitro data related to its bioresorbable stent platform—data that validates the Company’s approach to simultaneously balance biocompatibility, biomechanics and bioresorption in a bioresorbable PLA (polylactic acid) stent without altering healing by drug elution from the stent platform.

Back to news